Tech Company Financing Transactions
Girihlet Funding Round
On 9/30/2016, Girihlet received $2.7 million in funding from SOSV, True Ventures and private investors.
Transaction Overview
Company Name
Announced On
9/30/2016
Transaction Type
Venture Equity
Amount
$2,650,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
355 30th St. Oakland Genome Center
Oakland, CA 94609
USA
Oakland, CA 94609
USA
Phone
Website
Email Address
Not Recorded
Overview
Girihlet works on profiling the T cell receptor repertoire accurately to develop an understanding of the immune system. An accurate view of the repertoire is a window into the immune system and the health of an individual.
Management Team
Browse more venture capital transactions:
Prev: 9/30/2016: Prowler.io venture capital transaction
Next: 9/30/2016: SQZ Biotechnologies venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document tech company VC transactions. All VC database entries reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs